Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 277

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 277
---
forceable; |

| • |     | others may be able to develop and/or practice technology that is similar to Kineta’s technology or aspects of Kineta’s technology but that is not covered by the claims of any of Kineta’s owned or in-licensed patents, should any such patents issue; |

| • |     | third parties may compete with Kineta in jurisdictions where Kineta does not pursue and obtain patent protection; |

| • |     | Kineta (or its licensors) might not have been the first to make the inventions covered by a pending patent application that Kineta owns or licenses; |

| • |     | Kineta (or its licensors) might not have been the first to file patent applications covering a particular invention; |

| • |     | others may independently develop similar or alternative technologies without infringing Kineta’s intellectual property rights; |

| • |     | Kineta may not be able to obtain and/or maintain necessary licenses on reasonable terms or at all; |

| • |     | third parties may assert an ownership interest in Kineta’s intellectual property and, if successful, such disputes may preclude Kineta from exercising exclusive rights, or any rights at all, over that intellectual property; |

| • |     | Kineta may not be able to maintain the confidentiality of its trade secrets or other proprietary information; |

| • |     | Kineta may not develop or in-license additional proprietary technologies that are patentable; and |

| • |     | the patents of others may have an adverse effect on Kineta’s business. |

**Should any of these events occur, they could significantly harm Kineta’s business and results of operation. 163

General Risk Factors Related to Kineta

As a public company, Kineta has incurred, and will continue to incur, significant costs, and its management is required to devote substantial time to new compliance initiatives.

As a public company, Kineta has incurred and will continue to incur significant legal, accounting, compliance and other expenses that it did not incur as a private company. In addition, the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), as well as rules subsequently implemented by the SEC, have imposed various requirements on public companies. In July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act that require the SEC to adopt